TFS Capital’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

TFS Capital’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-19,010	Closed	-$99K	–	1022
2016 Q4	$99K	Buy	19,010 +3,150	+20%	+$14.8K	0.03%	644
2016 Q3	$74K	Buy	+15,860	New	+$74K	0.02%	689
2014 Q4	–	Sell	-31,000	Closed	-$258K	–	1376
2014 Q3	$258K	Buy	+31,000	New	+$287K	0.02%	797
2014 Q2	–	Sell	-23,865	Closed	-$303K	–	1649
2014 Q1	$303K	Buy	+23,865	New	+$308K	0.02%	1009

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

TFS Capital's DSCI Position: Q1 2017 in Review

TFS Capital sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 19,010 shares — an estimated $99K sold.

TFS Capital first reported a position in DSCI in Q1 2014 and held it in 4 quarters. The position peaked at $303K in Q1 2014. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

TFS Capital reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
TFS Capital sold 19,010 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $99K.
TFS Capital first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 4 quarters.
TFS Capital's Derma Sciences, Inc. Common Stock (DE) position peaked at $303K in Q1 2014.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.